bladder urothelial carcinoma (Disease)

Synonyms:bladder transitional cell carcinoma, transitional cell carcinoma of bladder, urinary bladder urothelial carcinoma, urothelial bladder carcinoma

Id:DOID:4006

Description:A bladder carcinoma that has_material_basis_in transitional cells located_in the lining of the bladder.

Results found

Linked to

	Label	Description
	CAL29 Subject (Entity type)	A subject from LINCS produced as part of the LINCS project
	BC3C Subject (Entity type)	A subject from LINCS produced as part of the LINCS project
	VMCUB1 Subject (Entity type)	A subject from LINCS produced as part of the LINCS project
	L1000 LINCS DCIC 2021 MOAR008 BC3C 24H C01 testosterone 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ASG002 BC3C 24H O02 crizotinib 1.11uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 MOAR012 BC3C 24H L11 tetrandrine 3.33uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ASG002 CAL29 24H A10 taselisib 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ASG002 BC3C 24H D15 R-547 0.12uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ASG002 BC3C 24H K10 bortezomib 20uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 MOAR011 BC3C 24H N05 cilazapril 3.33uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

CAL29

Subject (Entity type)

A subject from LINCS produced as part of the LINCS project

BC3C

Subject (Entity type)

A subject from LINCS produced as part of the LINCS project

VMCUB1

Subject (Entity type)

A subject from LINCS produced as part of the LINCS project

L1000 LINCS DCIC 2021 MOAR008 BC3C 24H C01 testosterone 10uM

Biosample (Entity type)